Wednesday,
March 27 |
Meet
The Experts II |
- Behind
the Scenes at the Emerging Infectious Disease Journal
Peter Drotman, CDC, Atlanta, GA; Poly Potter, CDC, Atlanta, GA; Brian
Mahy, CDC, Atlanta, GA
- Prevention
Effectiveness
Martin
Meltzer, CDC, Atlanta, GA; Anne
Haddix, School of Public Health, Emory University, Atlanta,
GA
|
Plenary
Session V |
- Global
Drug Resistance: The Case of Streptococcus pneumoniae
Keith
Klugman, School of Public Health, Emory University, Atlanta,
GA
- Use
of Antiretroviral Agents in Developing Countries
Peter
Mugyenyi, Joint Clinical Research Center, Kampala, Uganda
|
Plenary
Session VI |
- Genetic
Susceptibility to Infectious Diseases
Janet McNicholl, CDC, Atlanta, GA
- Virology
of 1918 Flu Pandemic
Ann
Reid, Armed Forces Institute of Pathology, Washington, DC
|
Panel
Sessions |
Anatomy
of Emerging Infectious Diseases
- Impact
of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
Ermias
Belay, CDC, Atlanta, GA
- The
Agent: Prions as Emerging Infectious Particles
David
Bolton, New York State Institute for Basic Research, Staten
Island, NY
- The
Reservoir: Bovine Spongiform Encephalopathy and What's Been
Done About It
Dagmar
Heim, Swiss Federal Veterinary Office, Bern-Liebefeld, Switzerland
- The
Unfolding Variant (vCJD) Epidemic
Robert
Will, Western General Hospital, Edinburgh, United Kingdom
Antimicrobial
Resistance
- Computerized
Decision Support for Appropriate Antimicrobial Drug Prescribing
Matthew
Samore, University of Utah, Salt Lake City, UT
- Implications
of Gene Transfer and Inducible Resistance for Successful
Therapy
Abigail
Salyers, American Society for Microbiology, Washington,
DC
- Promoting
Appropriate Antimicrobial Drug Use in Developing Countries
Sayomporn
Sirinavin, Mahidol University, Bangkok, Thailand
- Prospects
for New Antimicrobial Drug Development: Industry Perspective
Gail
Cassell, Eli Lilly and Company, Indianapolis, IN
Emerging
Vaccines for Emerging Diseases
- Anthrax
Vaccines
Arthur
Friedlander, U.S. Army Medical Research Institute of Infectious
Diseases, Fort Detrick, MD
- Group
B Meningococcal Vaccines
Gustavo
Sierra, Finlay Institute, Havana, Cuba
- New
Technologies and Vaccine Development
Margaret
Ann Liu, Bill and Melinda Gates Foundation, Seattle, WA
- Rotavirus
Vaccines in Development
Rajiv
Bahn, All India Institute of Medical Sciences, New Delhi,
India
Foreign
Policy and Infectious Disease
- Emerging
Infectious Diseases: The World Bank Perspective
O.K.
Pannenborg, The World Bank, Washington, DC
- Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic
Model for Addressing Priority Infectious Diseases)
Bill
Steiger, U.S. Department of Health and Human Services, Washington
DC
Infectious
Diseases in Aging Populations
- Biology
of Aging
Steven
Castle, University of California at Los Angeles, Los Angeles,
CA
- Biology
of Immune Senescence
Richard
Miller, University of Michigan, Ann Arbor, MI
- HIV
in the Older Patient
Bradley
Bender, University of Florida, Gainesville, FL
- Impact
of Aging on the Epidemiology of Infections in Adults
Thomas
Yoshikawa, Charles R. Drew University of Medicine and Science,
Los Angeles, CA
|
|